GERD & Reflux Disease

GERD management spans lifestyle modification to surgical intervention with new pharmacological options. The session covers potassium-competitive acid blockers (vonoprazan, tegoprazan, fexuprazan), endoscopic anti-reflux procedures (TIF 2.0, Stretta, GERDx), magnetic sphincter augmentation (LINX), surgical fundoplication (Nissen, Toupet), and refractory GERD evaluation with impedance-pH testing. Discussion addresses Barrett's esophagus surveillance with WATS-3D, the comparison of medical vs surgical management long-term, GERD in pregnancy, extraesophageal GERD (laryngopharyngeal reflux), the role of bedtime PPI vs morning dosing, and the post-pandemic rising trend of GERD presentation in primary care.